ChiCTR2400086370 版本V1.0 版本创建时间2024/06/30 16:34:38 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400086370 

最近更新日期:

Date of Last Refreshed on:

2024-06-30 16:34:32 

注册时间:

Date of Registration:

2024-06-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

妊娠期糖尿病孕妇身体活动方案的构建与实证研究

Public title:

Construction and empirical study of a physical activity program for pregnant women with gestational diabetes mellitus

注册题目简写:

English Acronym:

研究课题的正式科学名称:

妊娠期糖尿病孕妇身体活动方案的构建与实证研究

Scientific title:

Construction and empirical study of a physical activity program for pregnant women with gestational diabetes mellitus

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈宝珠 

研究负责人:

陈宝珠 

Applicant:

Chen Baozhu 

Study leader:

Chen Baozhu 

申请注册联系人电话:

Applicant telephone:

+86 180 5018 9612

研究负责人电话:

Study leader's
telephone:

+86 180 5018 9612

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

249019056@qq.com

研究负责人电子邮件:

Study leader's E-mail:

249019056@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市仓山区金榕南路516号福州大学附属省立医院金山院区2号楼5楼2区

研究负责人通讯地址:

Area 2, 5/F, Building 2, Jinshan Campus, Provincial Hospital Affiliated to Fuzhou University, No. 516 Jinrong South Road, Cangshan District, Fuzhou City, Fujian Province, P.R. China

Applicant address:

District 2, 5th Floor, Building2, Jinshan Campus of Provincial Hospital Affiliated to Fuzhou University, 516 Jinrong South Road, Gulou District, Fuzhou, Fujian

Study leader's address:

District 2, 5th Floor, Building2, Jinshan Campus of Provincial Hospital Affiliated to Fuzhou University, 516 Jinrong South Road, Gulou District, Fuzhou, Fujian

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福州大学附属省立医院金山院区

Applicant's institution:

Jinshan District, Affiliated Provincial Hospital of Fuzhou University

研究负责人所在单位:

福州大学附属省立医院金山院区

Affiliation of the Leader:

Jinshan District, Affiliated Provincial Hospital of Fuzhou University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

K2024-02-008

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建省立医院伦理委员会

Name of the ethic committee:

Fujian Provincial Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2024-02-18 00:00:00

伦理委员会联系人:

练发杨

Contact Name of the ethic committee:

Lian fayang

伦理委员会联系地址:

福建省福州市东街134号

Contact Address of the ethic committee:

134 East Street, Fuzhou City, Fujian Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 591 8821 6023

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福州大学附属省立医院

Primary sponsor:

Affiliated Provincial Hospital of Fuzhou University

研究实施负责(组长)单位地址:

福建省福州市仓山区金榕南路516号

Primary sponsor's address:

No. 516, Jinrong South Road, Cangshan District, Fuzhou City, Fujian Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福州大学附属省立医院

具体地址:

福建省福州市仓山区金榕南路516号

Institution
hospital:

Affiliated Provincial Hospital of Fuzhou University

Address:

No. 516, Jinrong South Road, Cangshan District, Fuzhou City, Fujian Province, China

经费或物资来源:

福建医科大学研究生课题经费

Source(s) of funding:

Fujian Medical University graduate project funding

研究疾病:

妊娠期糖尿病  

Target disease:

gestational diabetes mellitus

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)构建妊娠糖尿病孕妇身体活动方案。 (2)对构建的妊娠糖尿病孕妇身体活动方案进行临床实证研究,以期为该人群的健康管理提供新的参考依据。  

Objectives of Study:

(1) To construct a physical activity program for pregnant women with gestational diabetes. (2) To conduct a clinical empirical study on the constructed physical activity program for pregnant women with gestational diabetes mellitus, with a view to providing a new reference basis for the health management of this population.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄18-45岁;②根据国际糖尿病和妊娠研究组协会发布的 OGTT 试验诊断为 GDM 者;③具有完整的认知、行为能力 ;④既往体健,孕前无糖尿病,无妊娠期高血压、甲减等其他妊娠合并症;⑤知情同意,且自愿参与并配合本研究。

Inclusion criteria

① Age: 18-45; ② Diagnosed with GDM according to the OGTT test issued by the International Association of Diabetes and Pregnancy Research Groups; ③ Complete cognitive and behavioral ability ④ Previously physically fit, no diabetes mellitus before pregnancy, and no other pregnancy comorbidities, such as gestational hypertension and hypothyroidism; ⑤ Informed consent and voluntary participation and cooperation in this study.

排除标准:

①有运动禁忌症(胎膜早破、早产、持续性阴道出血、妊娠28周后出现前置胎盘、先兆子病、子宫颈内口松弛、胎儿宫内生长受限,其他严重的心血管、呼吸或全身性疾病障碍等);②人工受孕者;③双胞胎或多胎妊娠;④既往有严重精神病史、诊断有重度抑郁需经临床治疗者;⑤每周体力活动≥150分钟者;⑥排除有特殊饮食模式者。⑦参与本研究期间进行其他有计划、有监督的运动计划或研究者。

Exclusion criteria:

① contraindications to exercise (premature rupture of membranes, preterm labor, persistent vaginal bleeding, placenta praevia after 28 weeks of gestation, preeclampsia, endocervical relaxation, intrauterine growth restriction of the fetus, and other serious cardiovascular, respiratory, or systemic disease disorders, etc.); ② people with artificial insemination; ③ twins or multiple pregnancies; ④ people with a history of severe psychiatric illness, diagnosis of severe depression requiring clinical treatment; ⑤ people with ≥150 minutes of physical activity per week; ⑥ Those with special dietary patterns were excluded. ⑦ Participants in other planned and supervised exercise programs or studies during the study period.

研究实施时间:

Study execute time:

From 2024-06-30 00:00:00 To 2025-04-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-30 00:00:00 To 2025-01-31 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

43

Group:

Intervention group

Sample size:

干预措施:

实施妊娠期糖尿病身体活动常规指导+基于健康行动过程取向理论(HAPA)下的身体活动方案指导

干预措施代码:

Intervention:

Implementation of physical activity routines for gestational diabetes + physical activity program instruction based on Health Action Process Orientation Theory (HAPA)

Intervention code:

组别:

对照组

样本量:

43

Group:

Control group

Sample size:

干预措施:

实施妊娠期糖尿病身体活动常规指导

干预措施代码:

Intervention:

Implementing a physical activity routine guide for gestational diabetes mellitus

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福州大学附属省立医院 

单位级别:

三甲 

Institution
hospital:

Fujian Medical University graduate project funding

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

身体活动水平

指标类型:

主要指标

Outcome:

Physical activity level

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

空腹、三餐后2h的血糖平均值

指标类型:

主要指标

Outcome:

Mean values of blood glucose in fasting, 2h after three meals

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

身体活动依从性

指标类型:

主要指标

Outcome:

Physical activity compliance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

运动自我效能

指标类型:

次要指标

Outcome:

Exercise self-efficacy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑

指标类型:

次要指标

Outcome:

Anxiety

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

母婴结局

指标类型:

次要指标

Outcome:

Mother and child ending

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 45 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

随机化是由一名没有参与患者招募、评估或数据分析的研究人员完成的。由该人员进入随机化网站(www.random.org)产生一套随机数字,范围为1-86,共86个随机数字,并书写随机数字,分别装入按顺序编码、不透明和密封的信件中。

Randomization Procedure (please state who generates the random number sequence and by what method):

Randomization was done by a researcher who was not involved in patient recruitment, evaluation, or data analysis. The person accessed the randomization website (www.random.org) to generate a set of random numbers ranging from 1-86, for a total of 86 random numbers, and wrote the random numbers, which were individually placed in sequentially coded, opaque, and sealed letters.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

本研究对研究对象、资料收集人员、数据管理和统计资料分析设置盲法,设盲的研究人员不了解研究的分组情况和具体干预内容。将在随机分组后,仅告知研究对象分配给他们的干预方案,而对另一组的干预内容保密,孕妇也将被告知不要谈论所在组别的活动计划内容,直至研究结束为止,干预组与对照组的研究对象互不了解另一组的干预情况。数据收集者不了解干预分组情况,数据录入时将分组用A、B 表示,待所有的统计分析完成后揭盲。

Blinding:

This study will be blinded to the study participants, data collectors, data management and analysis of statistics, and the blinded researchers will not be informed about the grouping of the study and the specific intervention content. Research subjects will be informed only of the intervention program assigned to them after randomization into groups and the content of the intervention in the other group will be kept confidential, and pregnant women will be told not to talk about the content of the program of activities in their group until the end of the study, and the research subjects in the intervention group and the control group will not be informed of the intervention in the other group to each other. The data collectors were not informed about the intervention groups and the groups were denoted as A and B during data entry and were blinded after all statistical analyses were completed.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

我们将以论文的形式公布试验方案,有需要原始数据的科研工作者可以通过联系通讯作者获取。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

We will publish the experimental protocol in the form of a paper, and researchers who need the original data can obtain it by contacting the corresponding author.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由经过专门培训的资料收集员对数据进行测量和采集。采用Excel 建立数据库,为保证数据录入的准确性,所有数据均双人录入;采用SPSS软件进行数据处理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data is measured and collected by specially trained data collectors. Excel was used to establish the database. In order to ensure the accuracy of data entry, all data were recorded by two people. SPSS software was used for data processing.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-06-30 16:34:32